{"disease":{"id":"car-t-cell-therapy","name":"car t cell therapy"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT06295965","title":"Clonal Hematopoiesis and Therapy-Emergent Myeloid Neoplasms in Patients With Cancers, CHANCES Study","phase":"","overall_status":"RECRUITING","enrollment_count":2000,"lead_sponsor_name":"University of Washington","has_results":false},{"nct_id":"NCT05038254","title":"Enhanced Outpatient Symptom Management to Reduce Acute Care Visits Due to Chemotherapy-Related Adverse Events","phase":"NA","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":750,"lead_sponsor_name":"M.D. Anderson Cancer Center","has_results":false},{"nct_id":"NCT07424157","title":"Long-Term Follow-Up of Subjects Treated With Seattle Children's Therapeutics Gene Therapy Products","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":500,"lead_sponsor_name":"Seattle Children's Hospital","has_results":false},{"nct_id":"NCT07329920","title":"Mesenchymal CTC Ratio Dynamics Predicts Response and Survival in Pancreatic Ductal Adenocarcinoma With Neoadjuvant/Conversion Therapy","phase":"","overall_status":"COMPLETED","enrollment_count":300,"lead_sponsor_name":"Guo ShiWei","has_results":false},{"nct_id":"NCT07269587","title":"A Real-world Study on the Treatment of Adult B-cell Acute Lymphoblastic Leukemia With CNCT-19","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":275,"lead_sponsor_name":"Ruijin Hospital","has_results":false},{"nct_id":"NCT06535607","title":"Study of Volrustomig as Monotherapy or in Combination With Anti- Cancer Agents in Participants With Advanced/Metastatic Solid Tumors","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":257,"lead_sponsor_name":"AstraZeneca","has_results":false},{"nct_id":"NCT06571396","title":"Perioperative Risk of Immunotherapy Based Neoadjuvant and Conversion Therapy for Hepatocellular Carcinoma","phase":"","overall_status":"RECRUITING","enrollment_count":200,"lead_sponsor_name":"Qilu Hospital of Shandong University","has_results":false},{"nct_id":"NCT06575712","title":"Coping Skills Training for Symptom Management and Daily Steps (Step Up)","phase":"NA","overall_status":"RECRUITING","enrollment_count":177,"lead_sponsor_name":"Duke University","has_results":false},{"nct_id":"NCT07289087","title":"Patient-Reported Outcomes in Allogeneic Stem Cell Transplantation and CAR-T Therapy","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":162,"lead_sponsor_name":"Associazione Qol-one","has_results":false},{"nct_id":"NCT03517488","title":"A Study of XmAb®20717 in Subjects With Selected Advanced Solid Tumors","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":150,"lead_sponsor_name":"Xencor, Inc.","has_results":false},{"nct_id":"NCT01970540","title":"Study Escalating Doses of PM01183 in Combination With Fixed Doxorubicin in Patients With Specific Advanced Unresectable Solid Tumors","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":122,"lead_sponsor_name":"PharmaMar","has_results":true},{"nct_id":"NCT06993766","title":"The Predictability of CD19 Expression Across Primitive Cellular Fractions of Relapsed B-ALL on Outcomes of CD19-targeted CAR T-cells","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":100,"lead_sponsor_name":"King Faisal Specialist Hospital & Research Center","has_results":false},{"nct_id":"NCT06665295","title":"THRIVE-CAR-T Digital App","phase":"NA","overall_status":"RECRUITING","enrollment_count":100,"lead_sponsor_name":"Patrick C. Johnson, MD","has_results":false},{"nct_id":"NCT06643221","title":"Exercise as an Immune Adjuvant for Allogeneic Cell Therapies","phase":"EARLY_PHASE1","overall_status":"RECRUITING","enrollment_count":100,"lead_sponsor_name":"University of Arizona","has_results":false},{"nct_id":"NCT06554951","title":"Study of Extracellular Vesicles (EV) in Patients Undergoing CAR-T Cell Therapies","phase":"","overall_status":"RECRUITING","enrollment_count":100,"lead_sponsor_name":"IRCCS Azienda Ospedaliero-Universitaria di Bologna","has_results":false},{"nct_id":"NCT05311566","title":"PD-1 Antibody Plus Chemoradiotherapy for IB2-IIIB Cervical Cancer","phase":"PHASE2","overall_status":"UNKNOWN","enrollment_count":92,"lead_sponsor_name":"Lei Li","has_results":false},{"nct_id":"NCT06632093","title":"HAIC in Combination with PD-1 Inhibitors and Lenvatinib for Intermediate and Advanced HCC After the Failure of Systemic Therapy Recommended by BCLC","phase":"","overall_status":"RECRUITING","enrollment_count":84,"lead_sponsor_name":"First Hospital of China Medical University","has_results":false},{"nct_id":"NCT05099237","title":"Enhanced Monitoring for Better Recovery and Cancer Experience in Greater Manchester","phase":"NA","overall_status":"UNKNOWN","enrollment_count":80,"lead_sponsor_name":"Manchester University NHS Foundation Trust","has_results":false},{"nct_id":"NCT04280133","title":"CAR T-CELL Therapy Educational Video Trial","phase":"NA","overall_status":"UNKNOWN","enrollment_count":80,"lead_sponsor_name":"Massachusetts General Hospital","has_results":false},{"nct_id":"NCT06935136","title":"Study to Evaluate the Efficacy and Safety of Axicabtagene Ciloleucel Injection as First-Line Therapy of High-Risk Large B-Cell Lymphoma","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":60,"lead_sponsor_name":"Ruijin Hospital","has_results":false},{"nct_id":"NCT07120633","title":"Anti CD19 CAR-T Combined With BTKi to Treat Newly Diagnosed High-risk CLL/SLL","phase":"NA","overall_status":"RECRUITING","enrollment_count":50,"lead_sponsor_name":"The Affiliated Hospital of Xuzhou Medical University","has_results":false},{"nct_id":"NCT07339488","title":"Intestinal Low-Dose Radiotherapy Plus Immunochemotherapy for Conversion of Borderline Resectable/Unresectable Esophageal Squamous Cell Carcinoma","phase":"PHASE2","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":43,"lead_sponsor_name":"Chuangzhen Chen","has_results":false},{"nct_id":"NCT03101046","title":"Treatment of Metastatic Castrate Resistant Prostate Cancer Patients According to Circulating Tumor Cells Kinetic","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":40,"lead_sponsor_name":"UNICANCER","has_results":false},{"nct_id":"NCT04853277","title":"Patient Reported Outcomes and Patient Education in Cellular Therapy Patients","phase":"NA","overall_status":"COMPLETED","enrollment_count":31,"lead_sponsor_name":"Dartmouth-Hitchcock Medical Center","has_results":false},{"nct_id":"NCT07288879","title":"DALY II Japan/MB-CART2019.1 for DLBCL","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":31,"lead_sponsor_name":"Miltenyi Biomedicine GmbH","has_results":false},{"nct_id":"NCT07296120","title":"RSV Vaccine Response in Stem Cell and CAR-T Therapy Recipients","phase":"PHASE4","overall_status":"NOT_YET_RECRUITING","enrollment_count":30,"lead_sponsor_name":"The Cooper Health System","has_results":false},{"nct_id":"NCT06647329","title":"CAR-T Technology for Recurrent/Refractory Malignant Hematological and Lymphatic Tumors","phase":"PHASE1","overall_status":"NOT_YET_RECRUITING","enrollment_count":30,"lead_sponsor_name":"Mingzhi Zhang","has_results":false},{"nct_id":"NCT06196294","title":"GPC3/Mesothelin-CAR-γδT Cells Against Cancers","phase":"PHASE1","overall_status":"RECRUITING","enrollment_count":30,"lead_sponsor_name":"Second Affiliated Hospital of Guangzhou Medical University","has_results":false},{"nct_id":"NCT05779917","title":"Mesothelin/GPC3/GUCY2C-CAR-T Cells Against Cancers","phase":"PHASE1","overall_status":"RECRUITING","enrollment_count":30,"lead_sponsor_name":"Second Affiliated Hospital of Guangzhou Medical University","has_results":false},{"nct_id":"NCT04221893","title":"Radiation Therapy for the Treatment of Metastatic Gastrointestinal Cancers","phase":"NA","overall_status":"RECRUITING","enrollment_count":28,"lead_sponsor_name":"University of California, San Francisco","has_results":false},{"nct_id":"NCT07178431","title":"MB-CART2019.1 in Refractory Multiple Sclerosis","phase":"PHASE1, PHASE2","overall_status":"NOT_YET_RECRUITING","enrollment_count":26,"lead_sponsor_name":"Miltenyi Biomedicine GmbH","has_results":false},{"nct_id":"NCT07246304","title":"TC-D101 Cell Therapy for Patients With DLL3-Positive SCLC","phase":"EARLY_PHASE1","overall_status":"RECRUITING","enrollment_count":24,"lead_sponsor_name":"TCRCure Biopharma Ltd.","has_results":false},{"nct_id":"NCT04183218","title":"Characterizing Chemo-Radiotherapy Treatment-Related Cardiac Changes","phase":"","overall_status":"COMPLETED","enrollment_count":24,"lead_sponsor_name":"Mayo Clinic","has_results":false},{"nct_id":"NCT06839976","title":"CD19-Directed Chimeric Antigen Receptor Autologous T Cells (CART19) for Lupus","phase":"PHASE1, PHASE2","overall_status":"RECRUITING","enrollment_count":24,"lead_sponsor_name":"Children's Hospital of Philadelphia","has_results":false},{"nct_id":"NCT07236151","title":"Sequential CD19/CD22 CAR-T Cell Therapy Following ASCT","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":23,"lead_sponsor_name":"The First Affiliated Hospital of Soochow University","has_results":false},{"nct_id":"NCT06222853","title":"Study of Therapeutic Efficacy of Anti-CD19 CAR-T Cells in Refractory Systemic Lupus Erythematosus","phase":"PHASE1","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":22,"lead_sponsor_name":"The Children's Hospital of Zhejiang University School of Medicine","has_results":false},{"nct_id":"NCT04501913","title":"Remote Telemonitoring of Patient-Generated Physiologic Health Data and Patient-Reported Outcomes","phase":"","overall_status":"COMPLETED","enrollment_count":22,"lead_sponsor_name":"City of Hope Medical Center","has_results":false},{"nct_id":"NCT07198867","title":"A Study of A-CAR028 Treatment in Subjects With Relapsed or Refractory Acute Myeloid Leukemia","phase":"PHASE1","overall_status":"RECRUITING","enrollment_count":20,"lead_sponsor_name":"First Affiliated Hospital of Zhejiang University","has_results":false},{"nct_id":"NCT06921980","title":"Brain Function and Psychological Changes Related to Cell Therapy for Autoimmune Hemolytic Anemia","phase":"","overall_status":"RECRUITING","enrollment_count":20,"lead_sponsor_name":"Institute of Hematology & Blood Diseases Hospital, China","has_results":false},{"nct_id":"NCT06934447","title":"Study of BCMA/CD70 CAR-T Therapy for Refractory cSLE","phase":"PHASE1","overall_status":"RECRUITING","enrollment_count":18,"lead_sponsor_name":"The Children's Hospital of Zhejiang University School of Medicine","has_results":false},{"nct_id":"NCT06553898","title":"Study of Therapeutic Efficacy of CAR-T Cell Therapy in Patients With MDR-SRNS","phase":"PHASE1","overall_status":"RECRUITING","enrollment_count":18,"lead_sponsor_name":"The Children's Hospital of Zhejiang University School of Medicine","has_results":false},{"nct_id":"NCT05858684","title":"Dual Target CAR-T Cell Treatment for Refractory Systemic Lupus Erythematosus (SLE) Patients","phase":"EARLY_PHASE1","overall_status":"UNKNOWN","enrollment_count":18,"lead_sponsor_name":"RenJi Hospital","has_results":false},{"nct_id":"NCT07383233","title":"CD19/BAFF-R in Vivo CAR-T Cell Therapy Targeting Relapsed/Refractory B Cell Acute Leukemia/Malignant Lymphoma","phase":"PHASE1","overall_status":"NOT_YET_RECRUITING","enrollment_count":18,"lead_sponsor_name":"Qi deng","has_results":false},{"nct_id":"NCT06842589","title":"Study of Therapeutic Efficacy of Anti-CD19 CAR-T Cell Therapy in Patients With MDR-SRNS","phase":"PHASE1","overall_status":"RECRUITING","enrollment_count":18,"lead_sponsor_name":"The Children's Hospital of Zhejiang University School of Medicine","has_results":false},{"nct_id":"NCT06622694","title":"CD7 CAR T Cells (RD13-02) in the Treatment of Relapsed/Refractory Severe Aplastic Anemia","phase":"PHASE1","overall_status":"RECRUITING","enrollment_count":15,"lead_sponsor_name":"Institute of Hematology & Blood Diseases Hospital, China","has_results":false},{"nct_id":"NCT07505199","title":"Safety and Efficacy of FAP iCDC in Ischemia Cardiomyopathy","phase":"PHASE1","overall_status":"NOT_YET_RECRUITING","enrollment_count":15,"lead_sponsor_name":"Second Affiliated Hospital, School of Medicine, Zhejiang University","has_results":false},{"nct_id":"NCT05752877","title":"Safety and Efficacy of Targeted IL-13 Rα2 or B7-H3 UCAR-T for Advanced Glioma","phase":"NA","overall_status":"RECRUITING","enrollment_count":12,"lead_sponsor_name":"Second Affiliated Hospital of Soochow University","has_results":false},{"nct_id":"NCT06508346","title":"Study of Therapeutic Efficacy of Anti-CD19 CAR-T Cells in Children With Refractory Refractory AAV","phase":"","overall_status":"RECRUITING","enrollment_count":12,"lead_sponsor_name":"The Children's Hospital of Zhejiang University School of Medicine","has_results":false},{"nct_id":"NCT05354973","title":"ePRO for the Timely Detection of Side Effects in Cancer Patients Undergoing CAR T Immunotherapy","phase":"","overall_status":"RECRUITING","enrollment_count":11,"lead_sponsor_name":"Stiftung Swiss Tumor Institute","has_results":false},{"nct_id":"NCT04460937","title":"Testing the Addition of an Anti-cancer Drug, Adavosertib, to Radiation Therapy for Patients With Incurable Esophageal and Gastroesophageal Junction Cancers","phase":"PHASE1","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":4,"lead_sponsor_name":"National Cancer Institute (NCI)","has_results":true}],"total":50},"guidelines":[],"source":"Drug Landscape verified database"}